Stay updated with breaking news from Aileen Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunocompromised patients remain frightened and frustrated that vaccines aren’t offering enough protection as everyone else moves on. Scientists are racing to figure out what will work.
The clearances for the conduct of the country’s eight month-long Ivermectin clinical trial are expected to be released within this month, the Department of Science and Technology (DOST) said Friday, Jan. 7. Ivermectin pills (Photo courtesy of IndiaMart via PNA) “All clearances are anticipated t
The Department of Science and Technology (DOST) has explained why the country’s eight month-long clinical trial seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolati
The Department of Science and Technology (DOST) said Sunday, Oct. 31, that the eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolati
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year.